A study by researchers at the University of Mississippi Medical Center (UMMC) and the University of California, San Francisco (UCSF) shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders. The findings suggest that taking a certain class of antidepressants known as selective serotonin reuptake […]
Prolonged exposure therapy, cognitive therapy, and delayed prolonged exposure therapy, appear to reduce posttraumatic stress disorder symptoms in patients who have experienced a recent traumatic event, according to a report published Online First by Archives of General Psychiatry, one of the JAMA/Archives journals. The study was conducted by Arieh Y. Shalev, M.D., and colleagues from Hadassah […]
Children and teens with obsessive-compulsive disorder (OCD) who were receiving some benefit from treatment with medication had a significantly greater reduction in OCD symptoms with the addition of cognitive behavior therapy (CBT), according to a study in the September 21 issue of JAMA. The study was carried out by Martin E. Franklin, Ph.D., of the […]
Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found. The research, published on bmj.com, discovered that selective serotonin reuptake inhibitors (SSRIs) are more strongly associated with […]
Prenatal exposure to selective serotonin reuptake inhibitors, especially during the first trimester, is associated with a modest increase the risk of developing an autism spectrum disorder, according to a report published Online First in the Archives of General Psychiatry, one of the JAMA/Archives journals. The research was conducted by Lisa A. Croen, Ph.D., of Kaiser […]
A notable prevalence of childhood abuse – physical, sexual, verbal, or emotional – in migraine patients has been observed and documented over the last few years. In fact, it has emerged as a significant enough issue for the American Headache Society to devote an entire plenary session to it at its annual scientific conference in […]
Taking two medications for depression does not hasten recovery from the condition that affects 19 million Americans each year, researchers at UT Southwestern Medical Center have found in a national study, which is available online today and is scheduled for publication in an upcoming issue of the American Journal of Psychiatry.
Scientists at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin, and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications – the selective serotonin reuptake inhibitors, or SSRIs, taken for […]
Recent Comments